These success, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two support the thought of targeting ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected Diseases. By ticking this box and https://galileoo273ovb7.signalwiki.com/user